2018
Laparoscopic Ligation of Uterine Vasculature for Fertility-Sparing Management of Postabortal Hemorrhage
Menderes G, Leon-Martinez D, Azodi M. Laparoscopic Ligation of Uterine Vasculature for Fertility-Sparing Management of Postabortal Hemorrhage. Journal Of Minimally Invasive Gynecology 2018, 26: 36-37. PMID: 29609031, DOI: 10.1016/j.jmig.2018.03.020.Peer-Reviewed Original ResearchConceptsUterine artery embolizationLaparoscopic ligationUterine vasculaturePostabortal hemorrhageArtery embolizationBlood lossUterine vesselsMedical managementPelvic sidewallBilateral uterine artery embolizationApproximate blood lossFamily planning guidelinesFertility sparing managementIntrauterine tamponade balloonLeft pelvic sidewallRight pelvic sidewallTertiary referral centerIntrauterine balloon tamponadeUneventful postoperative courseWeeks of pregnancyPlacenta accretaUterine massageVaginal bleedingBalloon tamponadeHemodynamic instability
2015
Controlled removal of a large uterus within a bowel bag and morcellation in the bowel bag from the vagina
English D, Menderes G, Azodi M. Controlled removal of a large uterus within a bowel bag and morcellation in the bowel bag from the vagina. Gynecologic Oncology 2015, 137: 589-590. PMID: 25797081, DOI: 10.1016/j.ygyno.2015.03.014.Peer-Reviewed Original ResearchA Technique for Vascular Control During Robotic-assisted Laparoscopic Myomectomy
Donat LC, Menderes G, Tower AM, Azodi M. A Technique for Vascular Control During Robotic-assisted Laparoscopic Myomectomy. Journal Of Minimally Invasive Gynecology 2015, 22: 543. PMID: 25680685, DOI: 10.1016/j.jmig.2015.02.003.Peer-Reviewed Original ResearchConceptsRobotic-assisted myomectomyBlood lossVascular controlUterine vesselsVascular clipsUtero-ovarian vesselsUterine artery occlusionJehovah's Witness patientsExperienced laparoscopic surgeonsRobotic-assisted approachesArtery occlusionUterine arteriesBlood transfusionPeritoneal windowSurgical morbidityLaparoscopic myomectomyFertility preservationSymptomatic leiomyomasSubserosal injectionBulldog clampsMyomectomyRobotic myomectomyTemporary occlusionLaparoscopic surgeonsRobotic approach
2013
Robotic Versus Abdominal Hysterectomy for Very Large Uteri
Silasi DA, Gallo T, Silasi M, Menderes G, Azodi M. Robotic Versus Abdominal Hysterectomy for Very Large Uteri. JSLS Journal Of The Society Of Laparoscopic & Robotic Surgeons 2013, 17: 400-406. PMID: 24018076, PMCID: PMC3771758, DOI: 10.4293/108680813x13693422521755.Peer-Reviewed Original ResearchConceptsBody mass indexLaparotomy groupUteri weighingRobotic groupBlood lossUterine weightOperative timeMass indexMedian body mass indexRobotic surgeryLaparotomy control groupLarge myomatous uterusMedian blood lossMedian uterine weightIntraoperative blood lossMedian operating timeMorbidly obese patientsOutcomes of patientsPostoperative day 1Shorter hospital stayRetrospective chart reviewUnderwent hysterectomyAbdominal hysterectomyHospital stayMedian hospitalRobotic Repair of Uterine Dehiscence
La Rosa MF, McCarthy S, Richter C, Azodi M. Robotic Repair of Uterine Dehiscence. JSLS Journal Of The Society Of Laparoscopic & Robotic Surgeons 2013, 17: 156-160. PMID: 23743391, PMCID: PMC3662738, DOI: 10.4293/108680812x13517013317996.Peer-Reviewed Original ResearchConceptsUterine scar dehiscenceScar dehiscenceCesarean scarCesarean deliveryRobotic repairMultiple cesarean deliveriesSuccessful robotic repairNumber of complicationsPersistent vaginalUterine dehiscenceCommon complicationMore patientsTreatment guidelinesRobotic surgeryDehiscenceComplicationsFurther studiesPatientsSignificant increaseMonthsRepairScarDeliverySurgeryVaginal
2011
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody
Raji R, Guzzo F, Carrara L, Varughese J, Cocco E, Bellone S, Betti M, Todeschini P, Gasparrini S, Ratner E, Silasi DA, Azodi M, Schwartz P, Rutherford TJ, Buza N, Pecorelli S, Santin AD. Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. Journal Of Experimental & Clinical Cancer Research 2011, 30: 106. PMID: 22075385, PMCID: PMC3224774, DOI: 10.1186/1756-9966-30-106.Peer-Reviewed Original ResearchConceptsAntibody-dependent cellular cytotoxicityAnti-Trop-2 antibodyTrop-2Cell linesEffective treatment optionChromium release assaysComplement-dependent cytotoxicityCarcinosarcoma cell lineCell surface markersOvarian carcinosarcomaTreatment optionsControl antibodyHRS7Cellular cytotoxicityHigher positivityTherapeutic strategiesHuman uterineTumor tissueFlow cytometryImmunohistochemistryRT-PCRSurface expressionAntibodiesHuman IgGCarcinosarcoma